VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $197.98)
- $197.98 P/E (TTM): 20.86X Cap: $393M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $175.37)
- $175.37 P/E (TTM): 20.63X Cap: $8.67B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $53.57)
- $53.57 Cap: $21.15B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $197.98)
- $197.98 P/E (TTM): 20.86X Cap: $393M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $175.37)
- $175.37 P/E (TTM): 20.63X Cap: $8.67B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $60.14)
- $60.14 Cap: $5.77B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $197.98)
- $197.98 P/E (TTM): 20.86X Cap: $393M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $781.67)
- $781.67 P/E (TTM): 18.97X Cap: $82.63B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $248.43)
- $248.43 P/E (TTM): 22.29X Cap: $598.69B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,051.99)
- $1,051.99 P/E (TTM): 46.12X Cap: $992.40B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $123.82)
- $123.82 P/E (TTM): 16.37X Cap: $306.13B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $27.65)
- $27.65 P/E (TTM): 15.73X Cap: $157.22B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $521.11)
- $521.11 P/E (TTM): 29.83X Cap: $193.58B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $37.45)
- $37.45 P/E (TTM): 13.18X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $175.37)
- $175.37 P/E (TTM): 20.63X Cap: $8.67B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $53.57)
- $53.57 Cap: $21.15B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $197.98)
- $197.98 P/E (TTM): 20.86X Cap: $393M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $91.84)
- $91.84 P/E (TTM): 21.49X Cap: $1.05B
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023